妊娠期乳腺癌的诊治研究进展

doi:10.3760/cma.j.issn.1673-422X.2013.11.016

摘要/Abstract

摘要： 妊娠期乳腺癌临床表现、病理、诊治、预后都有其特殊性。由于延迟诊断，患者的生存率低，预后较差。需临床医生尽早明确诊断，通过手术、放化疗等个体化综合治疗方案，改善患者预后，延长生存期。

Abstract: Pregnancy associated breast cancer (PABC) has many special characteristics, such as the clinical manifestation， pathology， diagnosis, treatment and prognosis. Due to the delay of diagnosis, the survival rate is low and the prognosis is poor. Early diagnosis and comprehensive individualized treatment with operation, radiotherapy and chemotherapy are needed to improve the prognosis of patients and prolong the survival period.

Key words: Pregnant women, Breast neoplasms, Diagnosis, Therapy

张硕, 汪孟森, 于甬华. 妊娠期乳腺癌的诊治研究进展[J]. 国际肿瘤学杂志, 2013, 40(11): 853-857.

ZHANG Shuo, WANG Meng-Sen, YU Yong-Hua. Diagnosis and treatment of pregnancy associated breast cancer[J]. Journal of International Oncology, 2013, 40(11): 853-857.

参考文献

［1］ Sophie E, McGrath, Alistair R. Chemotherapy for breast cancer in pregnancy: evidence and guidance for oncologists. Ther Adv Med Oncol, 2011, 3(2)：73-83. ［2］ Polyak K. Pregnancy and breast cancer: the other side of the coin. Cancer Cell, 2006, 9 (3)：151-153. ［3］李俊杰, 邵志敏. 妊娠期乳腺癌的诊治进展. 中国癌症杂志, 2007, 17(10)：824-827. ［4］ Navrozoglou I, Vrekoussis T, Kontostolis E, et al. Breast cancer during pregnancy: a minireview. Eur J Surg Oncol, 2008,34(8)：837-843. ［5］ Molckovsky A, Madarnas Y. Breast cancer in pregnancy: a literature review. Breast Cancer Res Treat， 2008，108(3)：333-338. ［6］李元仙, 项尖尖. 超声诊断妊娠哺乳期乳腺癌的价值. 中国妇幼保健, 2010, 25：1993-1994. ［7］姜军, 范林军. 妊娠哺乳期乳腺癌的几个临床问题. 中国实用妇科与产科杂志, 2008, 24(11)： 813-815. ［8］朱丽英. 妊娠哺乳期乳腺癌37例临床分析. 实用肿瘤学杂志, 2007, 21(5)：443-444. ［9］ Cardonick E, Gilmandyar D, Somer RA. Maternal and neonatal outcomes of dose-dense chemotherapy for breast cancer in pregnancy. Obstet Gynecol, 2012, 120(6)：1267-1272. ［10］牛占恩, 袁堂玲, 李霞, 等. 妊娠哺乳期乳腺癌6例临床分析并文献回顾. 现代肿瘤医学, 2008, 16(8)：1323-1326. ［11］ Gemignani ML. Breast cancer screening: why, when, and how many?. Clin Obstet Gynecol, 2011, 54(1)：125-132. ［12］ Azim HA Jr, Peccatori FA. Treatment of metastatic breast cancer during pregnancy: we need to talk!. Breast, 2008, 17(4)：426-428. ［13］ Gentilini O, Botteri E, Veronesi P, et al. Repeating conservative surgery after ipsilateral breast tumor reappearance: criteria for selecting the best candidates. Ann Surg Oncol, 2012 , 19(12)：3771-3776. ［14］ Azim HA Jr, Botteri E, Renne G, et al. The biological features and prognosis of breast cancer diagnosed during pregnancy: a casecontrol study. Acta Oncol, 2012, 51(5)：653-661. ［15］ Mondi MM, Cuenca RE, Ollila DW, et al. Sentinel lymph node biopsy during pregnancy: initial clinical experience. Ann Surg Oncol, 2007,14(1)：218-221. ［16］ Morris PG, King F, Kennedy MJ. Cytotoxic chemotherapy for pregnancyassociated breast cancer: single institution case series. J Oncol Pharm Pract, 2009, 15(4)：241-247. ［17］ Mir O, Berveiller P, Ropert S, et al. Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol, 2008, 19(4):607-613. ［18］ Loibl S, Han SN, von Minckwitz G. Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol, 2012,13(9)：887-896. ［19］ Cardonick E, Dougherty R, Grana G. Breast cancer during pregnancy: maternal and fetal outcomes. Cancer, 2010,16 (1)：76-82. ［20］ Skrablin S, Banovic V, Matkovic V. Adriamycin and cyclophosphamide chemotherapy in advanced breast cancer in pregnancy. Eur J Obstet Gynecol Reprod Biol, 2007,33(2)：251-252. ［21］ Mathelin C, Treisser A, Chenard MP, et al. Pregnancy and postpartum breast cancer: a prospective study. Anticancer Res, 2008, 28(4C):2447-2452. ［22］ Amant F, Deckers S, Van Calsteren K, et al. Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer, 2010, 46(18)：3158-3168. ［23］ Rajaraman P, Simpson J, Neta G, et al. Early life exposure to diagnostic radiation and ultrasound scans and risk of childhood cancer: casecontrol study. BMJ, 2011, 342:d472. ［24］余艳红, 周俊, 龚时鹏. 妊娠合并乳腺癌的诊治. 实用妇产科杂志, 2007, 23(9)：526-528. ［25］ Leal SC, Stuart SR, Carvalho Hde A. Breast irradiation and lactation: a review. Expert Rev Anticancer Ther， 2013,13(2)：159-164. ［26］ Luis SA, Christie DR, Kaminski A, et al. Pregnancy and radiotherapy: management options for minimising risk, case series and comprehensive literature review. J Med Imaging Radiat Oncol, 2009,53(6)：559-568. ［27］ Ives A, Saunders C, Bulsara M. Pregnancy after breast cancer: population based study. BMJ, 2007,334(7586):194.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲. 血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	钱晓涛, 石子宜, 胡格, 吴晓维. Ⅲ~ⅣA期食管鳞状细胞癌放化疗后行巩固化疗的疗效：一项真实世界临床研究[J]. 国际肿瘤学杂志, 2024, 51(6): 326-331.
[3]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊. 局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[4]	袁健, 黄燕华. Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[5]	张百红, 岳红云. 新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[6]	许凤琳, 吴刚. EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[7]	王盈, 刘楠, 郭兵. 抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[8]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志. 宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.
[9]	陈琦, 徐晨阳, 王寅, 雷大鹏. 高光谱成像在头颈部肿瘤诊疗中的应用现状[J]. 国际肿瘤学杂志, 2024, 51(5): 298-302.
[10]	王培鑫, 赵军, 徐世红, 姜朝阳, 王小强, 杨红娟. 铁死亡相关机制在骨肉瘤中的应用进展[J]. 国际肿瘤学杂志, 2024, 51(5): 308-311.
[11]	王昆, 周中新, 臧其威. 血清TGF-β1、VEGF水平对非小细胞肺癌患者单孔胸腔镜根治术后复发的预测价值[J]. 国际肿瘤学杂志, 2024, 51(4): 198-203.
[12]	萨蔷, 徐航程, 王佳玉. 乳腺癌免疫治疗研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 227-234.
[13]	杨智, 陆以乔, 顾花艳, 丁佳玲, 郭贵龙. 肿瘤微环境介导乳腺癌靶向治疗耐药的研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 235-238.
[14]	王子豪, 王宇, 杨鑫, 何艺, 莫兴奎, 袁涛. 铁死亡在骨肉瘤中的分子机制及相关治疗的研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 239-244.
[15]	张栋岩, 王品, 魏秋亚, 邓成伍, 魏相相, 高远飞, 王琛. 索凡替尼靶向联合卡培他滨和奥沙利铂治疗肝内胆管癌术后患者1例及文献复习[J]. 国际肿瘤学杂志, 2024, 51(4): 249-253.